Santa Cruz Biotechnology features a diverse variety of SULT4A1 monoclonal antibodies for advanced research in molecular biology. SULT4A1 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SULT4A1, or sulfotransferase 4A1, plays a significant role in the metabolism of neurotransmitters and drugs, influencing their bioavailability and activity. SULT4A1 is particularly relevant in neuropharmacology, as it participates in the sulfation of catecholamines and other compounds, affecting signaling pathways in the nervous system. Understanding SULT4A1 function is essential for revealing its involvement in various physiological and pathological processes. Researchers studying SULT4A1 can explore its expression patterns in different tissues and cellular compartments. SULT4A1 investigation can provide valuable information about drug metabolism and neurotransmitter regulation. Examining SULT4A1 activity helps advance our knowledge of neurological disorders and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SULT4A1 and its impact on human health.